Progression patterns in patients with advanced hepatocellular carcinoma treated with local therapy, targeted drugs, and PD-1/PD-L1 inhibitors
Saved in:
Main Authors: | Yanan Zhao, Di Wu, Quanjun Yao, Hang Yuan, Hongtao Hu, Hailiang Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2024-08-01
|
Series: | Central European Journal of Immunology |
Subjects: | |
Online Access: | https://www.termedia.pl/Progression-patterns-in-patients-with-advanced-hepatocellular-carcinoma-treated-with-local-therapy-targeted-drugs-and-PD-1-PD-L1-inhibitors,10,54650,1,1.html |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Prognostic Value of Peripheral Blood Inflammatory Markers in Hepatocellular Carcinoma Treated with Lenvatinib Combined with PD-1 Inhibitors
by: Xin Y, et al.
Published: (2025-01-01) -
Efficacy and safety of PD-1/PD-L1 inhibitors in advanced or recurrent endometrial cancer: a meta-analysis with trial sequential analysis of randomized controlled trials
by: Ji Ren, et al.
Published: (2025-01-01) -
Infiltration of CD8+ cytotoxic T-cells and expression of PD-1 and PD-L1 in ovarian clear cell carcinoma
by: Mengdi Fu, et al.
Published: (2025-02-01) -
Differences in immune-related toxicity between PD-1 and PD-L1 inhibitors: a retrospective cohort study in patients with advanced cancer
by: Cecilia Olsson Ladjevardi, et al.
Published: (2024-11-01) -
NUAK1 acts as a novel regulator of PD-L1 via activating GSK-3β/β-catenin pathway in hepatocellular carcinoma
by: Chao-Yan Yao, et al.
Published: (2025-02-01)